Ashton, Anthony W

Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration. [electronic resource] - Circulation research Aug 2004 - 372-9 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

1524-4571

10.1161/01.RES.0000138300.41642.15 doi


15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid--pharmacology
Animals
Bridged Bicyclo Compounds, Heterocyclic--pharmacology
Capillaries--cytology
Cell Movement--drug effects
Endothelial Cells--cytology
Endothelium, Vascular--cytology
Fatty Acids, Unsaturated
Focal Adhesions--drug effects
Humans
Hydrazines--pharmacology
Neovascularization, Physiologic--drug effects
Nitric Oxide--metabolism
Nitric Oxide Donors--pharmacology
Phosphorylation--drug effects
Protein Isoforms--antagonists & inhibitors
Protein Kinases--genetics
Protein Processing, Post-Translational--drug effects
Rats
Receptors, Thromboxane A2, Prostaglandin H2--antagonists & inhibitors
Recombinant Proteins--pharmacology
Signal Transduction--drug effects
Transfection
Umbilical Veins
Vascular Endothelial Growth Factor A--pharmacology